209 related articles for article (PubMed ID: 23777681)
1. Evidence base for vaccine introduction in Latin America and the Caribbean. Foreword.
Etienne CF
Vaccine; 2013 Jul; 31 Suppl 3():C1. PubMed ID: 23777681
[No Abstract] [Full Text] [Related]
2. Evidence base for new vaccine introduction in Latin America and the Caribbean.
Andrus JK; Walker DG
Vaccine; 2013 Jul; 31 Suppl 3():C2-3. PubMed ID: 23777687
[No Abstract] [Full Text] [Related]
3. Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: the ProVac experience.
Toscano CM; Jauregui B; Janusz CB; Sinha A; Clark AD; Sanderson C; Resch S; Ruiz Matus C; Andrus JK;
Vaccine; 2013 Jul; 31 Suppl 3():C12-8. PubMed ID: 23777685
[TBL] [Abstract][Full Text] [Related]
4. Historical perspectives on new vaccine introduction in Latin America and the Caribbean.
de Quadros C
Vaccine; 2013 Jul; 31 Suppl 3():C4-5. PubMed ID: 23777690
[No Abstract] [Full Text] [Related]
5. Beyond methods and studies: building institutions for better public spending on vaccination.
Glassman A
Vaccine; 2013 Jul; 31 Suppl 3():C10-1. PubMed ID: 23777682
[No Abstract] [Full Text] [Related]
6. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on sustainable vaccine introduction.
Hinman AR
Vaccine; 2013 Jul; 31 Suppl 3():C8-9. PubMed ID: 23777696
[No Abstract] [Full Text] [Related]
8. Systematic documentation of new vaccine introduction in selected countries of the Latin American Region.
de Oliveira LH; Toscano CM; Sanwogou NJ; Ruiz-Matus C; Tambini G; Roses-Periago M; Andrus JK
Vaccine; 2013 Jul; 31 Suppl 3():C114-22. PubMed ID: 23777684
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned.
de Oliveira LH; Trumbo SP; Ruiz Matus C; Sanwogou NJ; Toscano CM
Expert Rev Vaccines; 2016 Oct; 15(10):1295-304. PubMed ID: 26982434
[TBL] [Abstract][Full Text] [Related]
10. What do policy makers need to know? Lessons from the decision to add pneumococcal conjugate and rotavirus vaccines to the US immunization program.
Whitney CG; Parashar UD
Vaccine; 2013 Jul; 31 Suppl 3():C6-7. PubMed ID: 23777693
[No Abstract] [Full Text] [Related]
11. Methods and challenges for the health impact assessment of vaccination programs in Latin America.
Sartori AM; Nascimento Ade F; Yuba TY; Soárez PC; Novaes HM
Rev Saude Publica; 2015; 49():. PubMed ID: 26759964
[TBL] [Abstract][Full Text] [Related]
12. A Pan American Health Organization strategy for cervical cancer prevention and control in Latin America and the Caribbean.
Luciani S; Andrus JK
Reprod Health Matters; 2008 Nov; 16(32):59-66. PubMed ID: 19027623
[TBL] [Abstract][Full Text] [Related]
13. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.
Clark A; Jauregui B; Griffiths U; Janusz CB; Bolaños-Sierra B; Hajjeh R; Andrus JK; Sanderson C
Vaccine; 2013 Jul; 31 Suppl 3():C19-29. PubMed ID: 23777686
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean.
Andrus JK; Lewis MJ; Goldie SJ; García PJ; Winkler JL; Ruiz-Matus C; de Quadros CA
Vaccine; 2008 Aug; 26 Suppl 11():L80-7. PubMed ID: 18945405
[TBL] [Abstract][Full Text] [Related]
15. Progress in the introduction of rotavirus vaccine--Latin America and the Caribbean, 2006-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(47):1611-4. PubMed ID: 22129995
[TBL] [Abstract][Full Text] [Related]
16. Identifying unit costs for use in regional economic evaluation: an illustrative analysis of childhood pneumococcal conjugate vaccine in Latin America and the Caribbean.
Constenla D; Sinha A; Valencia JE; Gomez E; de la Hoz F; Valenzuela MT; de Quadros CA
Rev Panam Salud Publica; 2009 Nov; 26(5):458-68. PubMed ID: 20107698
[No Abstract] [Full Text] [Related]
17. ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.
Jauregui B; Janusz CB; Clark AD; Sinha A; Garcia AG; Resch S; Toscano CM; Sanderson C; Andrus JK
Vaccine; 2015 May; 33 Suppl 1():A21-7. PubMed ID: 25919164
[TBL] [Abstract][Full Text] [Related]
18. Progress in the introduction of the rotavirus vaccine in Latin America and the Caribbean: four years of accumulated experience.
de Oliveira LH; Danovaro-Holliday MC; Sanwogou NJ; Ruiz-Matus C; Tambini G; Andrus JK
Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S61-6. PubMed ID: 21183843
[TBL] [Abstract][Full Text] [Related]
19. Vaccination legislation in Latin America and the Caribbean.
Trumbo SP; Janusz CB; Jauregui B; McQuestion M; Felix G; Ruiz-Matus C; Andrus JK; Quadros CD
J Public Health Policy; 2013 Jan; 34(1):82-99. PubMed ID: 23407412
[TBL] [Abstract][Full Text] [Related]
20. Direct effects of pneumococcal conjugate vaccines among children in Latin America and the Caribbean.
Whitney CG; Toscano CM
Lancet Infect Dis; 2021 Mar; 21(3):306-308. PubMed ID: 32986995
[No Abstract] [Full Text] [Related]
[Next] [New Search]
